Abstract: A series of C7-substituted estra-1,3,5(10),6-tetraene-3,17β-diols were prepared as precursors to radiodiagnostic agents of breast cancer. The introduction of the olefin moiety at C6/C7 in the molecules was achieved through thermal elimination of the 6-hydroxy group in the corresponding estra-1,3,5(10)-triene-3,17β-diols.
INTRODUCTION
are complicated by the protective group, and even comparative in vitro testing among differently substituted estradiol-3-methyl ethers may not necessarily reflect the behaviour of the estradiols themselves. In the following, the synthesis of a series of non-protected cyanoalkyl-, amidoalkyl-, and N-butyl-N-methylamidoalkylestra-1, 3,5(10) ,6-tetraen-3,17 -diols is elaborated.
60-70% of breast cancer tumours are estrogen receptor positive [1] . The cells possess estrogen receptor ER in concentrations much greater than normal breast tissue. Potentially, this opens ways to target the cancer cells with both diagnostics and therapeutic agents, where a steroid can act as drug delivery system. One of the prerequisites expected of such compounds is a good binding affinity to ER . In our search for estradiol based radiodiagnostic agents for the detection of minimal breast cancer [2] , we have investigated a series of 17 -iodovinyl substituted estraVarious synthetic pathways to C7-substituted estradiols and estrones have been pursued. Initially, norandrostanes have been used as starting material, with the key step being a 1,6-addition of the chain comprising nucleophile to 17- 1, 3,5(10) ,6-tetraene-3,17 -diols 2 ( Fig. 1) . It is known that C-7 substituted estradiols can exhibit a strong binding affinity to the estrogen receptor ER [3, 4] . C-7 substituted estradiols, while studied to a much lesser degree, are deemed to exhibit a poorer binding to ER . For this reason it seemed of interest to focus on the behaviour of C7-substituted estra-1, 3,5(10),6-tetraen-3,17 -diols, e.g. 3, where the C7 substituent branches off from an sp 2 carbon of the steroidal framework ( Fig. 1) [5] . Former studies [5] have been limited to the synthesis of C7 substituted estratetraenediols with a protected, methylated phenolic function at C3 with the idea being that the prodrug would be demethylated in vivo. In vitro testing of the compounds, such as in vitro receptor binding affinity assays, however, protected 17 -hydroxy-19-norandrosta-4,6-dien-3-one 4 [3, 6] . As the synthesis necessitates an aromatisation of ring A in the latter part of the sequence, later approaches to C7-substituted estradiols utilized either estrone, estradiol or related estranes such as equiline as starting material [5, [7] [8] [9] . Recently, C7-substituted estradiols have been accessed via conjugate addition of a C7-chain electrophile to the enolates of 6-ketoestrane derivatives [5, 8] . In the preparation of C7-substituted estra-1,3,5(10),6-tetraenes, the 6-keto group is reduced after the introduction of the substituent at C7 to the corresponding hydroxy group, which subsequently is eliminated under acidic conditions. The dehydration is unproblematic, when the phenolic function at C3 is protected as a methyl ether. However, if the tethered chain at C7 carries a terminal functionality such as a cyano or amide group, it should be a C 5 chain or longer for the dehydration to proceed smoothly. Against this background, we undertook the synthesis of non-protected C7-substituted estra-1,3,5(10),6-tetraen-3,17 -diols following the latter synthetic approach utilizing the conjugate addition offunctionalized alkyliodides to a suitably protected 6-ketoestra-1,3,5(10)-trien-17-one.
protective group for HO(C3). With this choice, the envisaged sequence to the C7-substituted estra-1,3,5(10),6-tetraen-3,17 -diols was planned as follows: a) protection of HO(C3) and C17; b) oxidation of C6 to the 6-ketoderivative; c) conjugate addition of an -cyanoalkyl iodide or an -N-butyl-N-methylamidoalkyl iodide to the 6-keto derivative; d) reduction of the 6-keto group; e) acidic dehydration of the 6-hydroxy group with concomittant deprotection of HO(C3) and C17; f) facultative manipulation of the terminal functionality of the C7 side chain; g) addition of an ethynyl group to C17, both as a means to further the binding affinity of the molecule to the estrogen receptor and as a possible anchor for a radiolabel.
RESULTS AND DISCUSSION
Commercially estrone was chosen as starting material. Initially, a good choice of protective groups for the keto group at C17 and phenolic function at C3 is essential. While the choice of the dimethyldioxane as protective group for C17 was straightforward, the selection of the protective group for HO(C3) was much less so. From previous experiments, it was evident that deprotection of a steroidal methyl ether at the final stages of the sequence, i.e. by BBr 3 or TMSI, would only lead to success in a limited number of cases. The use of the benzyloxy group would mean a subsequent selective reductive cleavage, which at the stage of the C7 substituted estra-1,3,5(10),6-tetraene is not possible. Interestingly, it has been shown that hydrogenation of such molecules leads to hydrogenation of the C6/C7 olefin moiety concomittant with the debenzylation, to give selectively the C7 -substituted estra-1,3,5(10)-triene-3-ols [10] . Additionally, the benzyloxy group is partially oxidized in the preparation of the 6-ketoestrone derivatives. Acetoxyand trimethylsiloxy protective groups are too labile in the oxidation of the compound to the 6-keto derivatives. For this reason the tetrahydropyranyloxy group was chosen as Initial experiments to synthesize 3-O-THP-estra-1,3,5(10)-triene-3-ol-17-one 17-acetal from estrone (5) gave the desired compound only in low yield, independently of whether the acetalisation followed the protection of HO(C3) with THP or whether the reactions were carried out in reverse order. Rather than optimize the conditions for the above reaction, it was deemed more opportune to operate via the estrone 3-benzoate and to change protective groups just before the introduction of the C7 side chain. Thus, estrone (5) was reacted with benzoyl chloride (KOH, water, 0ºC) to estrone 3-benzoate, which was acetalized with neopentyl glycol (NPG, benzene, p-TsOH) to 6. A number of methods for the preparation of 6-ketoestrane derivatives of type 7 from suitably protected estrone and estradiol have been
ii. NC(CH 2 ) n I (10), -78˚C -0˚C i. KOBu t , THF, DME, 0˚C 11 using NC(CH 2 ) 4 I (10a) to obtain 11a [R = (CH 2 ) 4 CN]: 40% using NC(CH 2 ) 5 I (10b) to obtain 11b [R = (CH 2 ) 5 CN]: 43% using NC(CH 2 ) 6 I (10c) to obtain 11c [R = (CH 2 ) 6 CN]: 38% Scheme 2.
ii. I(CH 2 ) 10 CON(Me)Bu (12) Thereafter, the benzoate protective group was removed (KOH, THF, MeOH) and the resulting estra-1,3,5(10)-trien-3-ol-6,17-dione 17,17-dimethyldioxane (8) was reacted with dihydropyran (DHP) (CH 2 Cl 2 , p-TsOH) to give 9. 9 was transformed into its enolate (KOBu t , THF, DME [5, 7, 8] ), which was reacted with cyanoalkyl iodides 10 [12] and with N-butyl-N-methylamidoundecyl iodide (12) [12] to form 7 -substituted 11 and 13, respectively (Schemes 2 and 3) . The 6-keto group in 11 and 13 was reduced with NaBH 4 in MeOH to afford mainly the 6 -hydroxy compounds 14 and 18 (Schemes 4 and 5). -trien-3,6,17 -triol, an acidic dehydration does lead to a small amount of estra-1,3,5(10),6-tetraen-3,17 -diol, that is to the dehydrated product, where the THP group has been cleaved. Isolatable side product in this case is a dimer, where the benzylic cation of one molecule reacts with one molecule of product. Similar reactions have been noted in the acidic dehydration of tetrahydronaphthols, eg. of 16 (Fig. 2 ) [13] , where again dimers, e.g. 17, could be isolated. A transformation of the 6-hydroxy group in 14 to the corresponding tosylate or mesylate with subsequent base catalysed elimination does not succeed. Routes such as the direct transformation of the 6-keto derivatives to the corresponding tosylhydrazones with subsequent Shapiro reaction [5b], which had been developed successfully by the authors for steroids with short C-7 alkyl chains with terminal functionalities, which are also prone to oligomerize under acidic conditions, were deemed too laborious in the present case.
In 1962, V. J. Traynelis et al. [14] reported on a thermal dehydration of alcohols in DMSO. This very infrequently used reaction was utilized by H. J. Siemann et al. [15] in the dehydration of a 14,15-spirocyclopropane containing, albeit C7-unsubstituted 6-hydroxyestradiol derivative. Although the mechanism of this reaction is not clear, with V. J. Traynelis et al. giving some evidence for at least a partial cationic charge at C6 in the transition state, the experimental data suggests that no benzyl cation per se is involved. This led us to subject 14 to a thermolysis in DMSO at 150 -160ºC. The C7-substituted estra-1,3,5(10),6-tetraen-3-ol-17-ones 15 could be isolated in fair yield (Scheme 4). It must be noted that under the conditions both the THP protective group at HO(C3) as well as the acetal at C17 are cleaved. Incompletely run reactions indicate that the THP at HO(C3) is the first to cleave before appreciable amounts of either olefin formation or acetal deprotection takes place. The reaction is very temperature dependent. Temperatures lower than 150ºC leads mainly only to the deprotection of 14. Temperatures above 160ºC promote the oxidation of the benzylic alcohol to the corresponding 6-keto compounds. This latter reaction is also a side reaction in the temperature range of 150ºC -160ºC, even when the reactions are carried out under inert atmosphere. The best result for the thermolytic dehydration of amide 18 was found at slightly higher temperatures (175ºC) (Scheme 5).
The cyano function of the C7-side chain in 15 and analogous compounds can be elaborated further. Principally, the cyano group can be derivatised further to carboxylic acid, carbaldehyde or methylamine. In the present case, the cyano group in 20b and 20c was partially hydrolysed to form amides 21b and 21c (Scheme 6) [16] . In conclusion, a number of 7-cyanoalkyl and 7-amidoalkylsubstituted estra-1, 3,5(10),6-tetraen-3-ol-17-ones 15 and 19 and 17 -ethynylestra-1,3,5(10),16-diols 22, 24 , and 25 were synthesized as precursors to radiolabelled estra-1, 3,5(10),6-tetraen-3,17 -diols. Further reactions to the iodovinyl derivatives are currently underway. This transformation, which has been carried out successfully with the parent compound [2] , involves a hydrostannylation of the ethynyl group and a subsequent electrophilic substitution of the vinylstannane by radiolabelled iodine [Na 125 I or Na 123 I, chloroamine-T]. In vivo biodistribution studies in immature female mice of the radiolabelled compounds and in vitro estrogen receptor ER binding affinity assays of both the compounds presented here [19] and the radiolabelled compounds will follow shortly. Representative procedures to and data of the compounds: 7α-(Nbutyl-N-methylundecanamide)-3-O-tetrahydropyranyl-6-oxoestra-1,3,5(10)-triene-3-ol-17-one-17,17-dimethyldioxane (13).-To a solution of 9 (1.41 g, 3.12 mmol)) in anhydrous THF (3.3 mL) and anhydrous DME (27 mL) was added potassium tert-butoxide (507 mg, 4.51 mmol) under inert atmosphere at 0 ºC. After 1 h, 11-iodo-(N-butyl-N-methyl)undecanamide (12, 1.52 g, 3.98 mmol) was added at 0 ºC and the reaction mixture was stirred at rt for 10 h. Thereafter, water (100 mL) was added and the mixture was extracted with ether (2 x 100 mL). The organic phase was dried over Na 2 SO 4 , filtered and the solvent evaporated to dryness. The resulting crude was separated by column chromatography on silica gel (n-hexane/ethyl acetate 4:1→2:1) affording 22 (1.09 g, 49%) as a gel. IR (neat) 2930, 2858, 1679, 1640, 1491, 1468, 1107, 1038, 1022, 968, 811 13.82, 18.74, 18.81, 19.90, 20.01, 21.94, 22.21, 22.46, 25.08, 25.11, 25.46, 26.47, 26.86, 27.35, 29.28, 29.36, 29.43, 29.50, 29.67, 30.20, 30.26, 30.30, 30.60, 32.94, 33.16, 33.60, 35.25, 37.27, 42.63, 42.71, 42.86, 47.29, 47.32, 48.77, 48.84, 49.70, 62.08, 62.19, 70.68, 72.54, 96.24, 96.49, 108.31, 114.52, 122.20, 127.01, 127.04, 132.28, 132.32, 139.67, 139.69, 155.36, 155.45, 172.81, 172.93, 201. 
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